All posts by: Michael Zand

About Michael Zand

Kite Pharma’s CAR T-Cell Treatment Approved, Cheaper Than Tisagenlecleucel – AJMC.com Managed Markets Network

Continue reading

2017-10-19 NEWS

Kite Pharma’s CAR T-Cell Treatment Approved, Cheaper Than Tisagenlecleucel
AJMC.com Managed Markets Network
The FDA has given the go-ahead for a second chimeric antigen receptor (CAR) T cell therapy: axicabtagene ciloleucel (Yescarta), developed by Kite Pharma, which was recently acquired by Gilead Sciences, has been approved to treat adult patients with …

and more »

Continue reading

2017-10-19 NEWS

‘Stings & Things’: Noted Allergist Discusses Venom Immunotherapy at WRNMMC
Pentagram
Golden provided the Walter Reed Bethesda allergists, pediatricians and internal medicine primary care providers with clinical and research information pertaining to measures to avoid getting stung, risks for severity and dosing for venom immunotherapy

Continue reading

2017-10-19 NEWS

Forbes

PBS’s Documentary ‘The Gene Doctors’ Arrives Amid A Gene – Forbes
Forbes
A new PBS film educates viewers about gene therapy at a time when the once controversial field of research is starting to bear fruit.
First-of-Its-Kind Gene Therapy Could Treat BlindnessHealthline

all 5 news articles »